Form 4 for AXGN Axogen, Inc.

Accepted 2022-12-29 00:00:00 ET · period of report 2022-12-27 · accession 0000805928-22-000141 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-12-29	2022-12-27	AXGN	MARIANI PETER J	EVP, CFO	F - Tax	$9.44	-649	42.1K	-2%	-$6,127
D	2022-12-29	2022-12-27	AXGN	MARIANI PETER J	EVP, CFO	M - OptEx	$0.00	+2,625	42.8K	+7%	$0
D	2022-12-29	2022-12-27	AXGN	MARIANI PETER J	EVP, CFO	M - OptEx	$0.00	+2,625	2,625	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-12-27	F	D	649	$9.44	42,108	D	—	—	(F2) Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
2	Common	Common Stock	2022-12-27	M	A	2,625	$0.00	42,757	D	—	—	(F1) This reflects the number of restricted stock units that vested on December 27, 2022.
3	Derivative	Restricted Stock Units	2022-12-27	M	A	2,625	$0.00	2,625	D	— · — to —	2,625 Common Stock	(F3) Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. (F4) All shares of AxoGen Inc. common stock underlying the restricted stock units vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter.